세계의 핵산 표지 시장 보고서(2025년)
Nucleic Acid Labeling Global Market Report 2025
상품코드 : 1824424
리서치사 : The Business Research Company
발행일 : On Demand Report
페이지 정보 : 영문 250 Pages
 라이선스 & 가격 (부가세 별도)
US $ 4,490 ₩ 6,430,000
PDF (Single User License) help
PDF 보고서를 1명만 이용할 수 있는 라이선스입니다. 인쇄 가능하며 인쇄물의 이용 범위는 PDF 이용 범위와 동일합니다.
US $ 6,490 ₩ 9,294,000
PDF (Site License) help
PDF 보고서를 동일 사업장의 모든 분이 이용할 수 있는 라이선스입니다. 인쇄 가능하며 인쇄물의 이용 범위는 PDF 이용 범위와 동일합니다.
US $ 8,490 ₩ 12,159,000
PDF (Enterprise License) help
PDF 보고서를 동일 기업의 모든 분이 이용할 수 있는 라이선스입니다. 인쇄 가능하며 인쇄물의 이용 범위는 PDF 이용 범위와 동일합니다.


ㅁ Add-on 가능: 고객의 요청에 따라 일정한 범위 내에서 Customization이 가능합니다. 자세한 사항은 문의해 주시기 바랍니다.
ㅁ 보고서에 따라 최신 정보로 업데이트하여 보내드립니다. 배송기일은 문의해 주시기 바랍니다.

한글목차

핵산 표지 시장 규모는 향후 수년간 강력한 성장이 예상됩니다. 2029년에는 CAGR 9.7%로 40억 달러로 성장할 것으로 예상됩니다. 예측 기간의 성장은 사람들의 건강 의식 증가, 주요 세계 기업의 침투, 환자 중심 접근법에 대한 관심 증가, 생명 공학 분야의 성장, DNA 시퀀싱의 사용 증가 등에 기인합니다. 예측 기간의 주요 동향은 합성 생물학을 위한 도구의 진보, 표지 기술의 진보, 신규 표지 기술의 개발, 혁신적인 형광증백제, 연구 및 치료에 새로운 표지 기술의 통합 등이 있습니다.

향후 5년간의 성장률 9.7%라고 하는 예측은 전회의 예측으로부터 0.2%의 소폭 감소를 반영하고 있습니다. 이 감소는 주로 미국과 다른 국가 간의 관세의 영향 때문입니다. 관세 인상은 독일과 싱가포르에서 조달하는 형광 뉴클레오티드 프로브와 차세대 시퀀싱 시약의 비용을 높여 연구소의 운영비를 악화시켜 생물의학의 진보를 늦추어 미국 연구기관에 부담을 줄 가능성이 높습니다.

향후 예상되는 감염증 증가는 핵산 표지 시장의 성장을 견인할 것입니다. 감염은 기생충, 곰팡이, 바이러스, 박테리아와 같은 미세한 유기체에 의해 유발되며 직접 또는 간접 접촉으로 확산됩니다. 핵산 표지 기술은 결핵, 간염, 임질과 같은 감염의 검출을 향상시켜 특이성, 감도, 다중화 능력, 시각화, 실시간 모니터링 및 자동화를 향상시킵니다. 예를 들어, 2023년 3월 미국 질병 예방관리센터는 2022년 미국에서 결핵 환자 수가 8,300명으로 2021년 7,874명에서 증가했다고 보고했습니다. 2022년 결핵 이환율은 인구 10만 명당 2.5명으로 약간 증가했습니다. 따라서 감염의 급증은 핵산 표지 시장의 성장에 기여합니다.

목차

제1장 주요 요약

제2장 시장 특징

제3장 시장 동향과 전략

제4장 시장 : 금리, 인플레이션, 지정학, 무역전쟁과 관세, 그리고 코로나 및 회복이 시장에 미치는 영향을 포함한 거시경제 시나리오

제5장 세계의 성장 분석과 전략 분석 프레임워크

제6장 시장 세분화

제7장 지역별/국가별 분석

제8장 아시아태평양 시장

제9장 중국 시장

제10장 인도 시장

제11장 일본 시장

제12장 호주 시장

제13장 인도네시아 시장

제14장 한국 시장

제15장 서유럽 시장

제16장 영국 시장

제17장 독일 시장

제18장 프랑스 시장

제19장 이탈리아 시장

제20장 스페인 시장

제21장 동유럽 시장

제22장 러시아 시장

제23장 북미 시장

제24장 미국 시장

제25장 캐나다 시장

제26장 남미 시장

제27장 브라질 시장

제28장 중동 시장

제29장 아프리카 시장

제30장 경쟁 구도와 기업 프로파일

제31장 기타 주요 기업 및 혁신 기업

제32장 세계 시장 경쟁 벤치마킹과 대시보드

제33장 주요 인수합병(M&A)

제34장 최근 시장 동향

제35장 시장의 잠재력이 높은 국가, 부문, 전략

제36장 부록

SHW
영문 목차

영문목차

Nucleic acid labeling is the process of incorporating detectable tags or markers into DNA or RNA molecules. These tags serve the purpose of visualizing and detecting specific nucleic acid sequences or monitoring their presence, location, or activity in various experimental or diagnostic contexts.

The primary product types in nucleic acid labeling encompass kits, reagents, and instruments. Reagents refer to substances or compounds utilized in diagnostic tests or laboratory experiments to identify, analyze, or measure specific components in biological samples. Various labeling types include radioisotope or radioactive labels, non-radioactive labels, and diverse methods such as enzyme-based and chemical-based approaches. These applications find use in various techniques such as DNA sequencing, polymerase chain reaction, fluorescence in situ hybridization (FISH), microarrays, blotting, in situ hybridization, and others. Additionally, these products cater to diverse end-users including hospitals, clinics, diagnostic centers, and more.

Note that the outlook for this market is being affected by rapid changes in trade relations and tariffs globally. The report will be updated prior to delivery to reflect the latest status, including revised forecasts and quantified impact analysis. The report's Recommendations and Conclusions sections will be updated to give strategies for entities dealing with the fast-moving international environment.

The sharp rise in U.S. tariffs and the resulting trade tensions in spring 2025 are having a significant impact on the healthcare sector, especially in the supply of essential medical devices, diagnostic equipment, and pharmaceuticals. Hospitals and healthcare providers are grappling with higher costs for imported surgical tools, imaging systems, and consumables like syringes and catheters, many of which have limited domestic substitutes. These escalating expenses are putting pressure on healthcare budgets, prompting some providers to delay equipment upgrades or pass increased costs on to patients. Furthermore, tariffs on raw materials and components are disrupting the manufacturing of vital drugs and devices, leading to supply chain delays. In response, the industry is adopting diversified sourcing strategies, expanding local production where feasible, and pushing for tariff exemptions on critical medical products.

The nucleic acid labeling market research report is one of a series of new reports from The Business Research Company that provides nucleic acid labeling market statistics, including nucleic acid labeling industry global market size, regional shares, competitors with a nucleic acid labeling market share, detailed nucleic acid labeling market segments, market trends, and opportunities, and any further data you may need to thrive in the nucleic acid labeling industry. This nucleic acid labeling market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.

The nucleic acid labeling market size has grown strongly in recent years. It will grow from $2.56 billion in 2024 to $2.77 billion in 2025 at a compound annual growth rate (CAGR) of 8.0%. The growth in the historic period can be attributed to increased healthcare expenditure, rise in r&d spending, increased genomics research and disease diagnosis, increased demand for personalized medicine, healthcare infrastructure.

The nucleic acid labeling market size is expected to see strong growth in the next few years. It will grow to $4 billion in 2029 at a compound annual growth rate (CAGR) of 9.7%. The growth in the forecast period can be attributed to rising health awareness among people, growing penetration of key global players, increasing focus on patient-centered approaches, growing biotechnology sector, increasing use of dna sequencing. Major trends in the forecast period include advancements in tools for synthetic biology, advancements in labeling techniques, development of novel labeling techniques, innovative fluorescent dyes, integration of new labeling technologies in research and therapeutics.

The forecast of 9.7% growth over the next five years reflects a slight reduction of 0.2% from the previous projection. This reduction is primarily due to the impact of tariffs between the US and other countries. Tariff escalations are likely to burden U.S. research institutions by driving up the cost of fluorescent nucleotide probes and next-gen sequencing reagents sourced from Germany and Singapore, exacerbating lab operational expenses and slowing biomedical advancements The effect will also be felt more widely due to reciprocal tariffs and the negative effect on the global economy and trade due to increased trade tensions and restrictions.

The expected increase in infectious diseases is set to drive the growth of the nucleic acid labeling market in the future. Infectious diseases, caused by microscopic organisms such as parasites, fungi, viruses, and bacteria, spread through direct or indirect contact. Nucleic acid labeling techniques enhance the detection of infectious diseases such as tuberculosis, hepatitis, and gonorrhea, offering improved specificity, sensitivity, multiplexing capability, visualization, real-time monitoring, and automation. For example, in March 2023, the Centers for Disease Control and Prevention reported 8,300 cases of tuberculosis (TB) in the United States in 2022, reflecting a rise from 7,874 cases in 2021. The incidence of tuberculosis (TB) slightly increased to 2.5 incidents per 100,000 people in 2022. Thus, the surge in infectious diseases contributes to the growth of the nucleic acid labeling market.

The increasing funding for genomic research is expected to drive the growth of the nucleic acid labeling market. Such funds refer to financial resources dedicated to supporting scientific investigations and studies in genomics. This funding advances nucleic acid labeling by fostering the development of cutting-edge technologies, providing essential infrastructure, nurturing expertise, and facilitating collaboration. For instance, the National Human Genome Research Institute, a US-based government center, received $614 million in 2021 and $616 million in 2022. The proposed budget for 2023 allocates $629 million for the institute. Therefore, the rising funds for genomic research are propelling the growth of the nucleic acid labeling market.

A key trend gaining popularity in the nucleic acid labeling market is technological advancements. Major companies in the market are focusing on nanotechnology advancements to maintain their market positions. For instance, in January 2023, Cambridge Nucleomics, a UK-based biotechnology company, introduced a new technology called nano bait, which enables highly multiplexed detection of nucleic acid signatures caused by respiratory pathogens. This technology offers a faster solution for viral RNA detection compared to other techniques.

Major companies operating in the nucleic acid labeling market are making significant investments. Investments in nucleic acid labeling involve financial contributions to initiatives, companies, or projects related to nucleic acid labeling technologies, research, and development. In January 2023, Agilent Technologies Inc., a US-based provider of software and instruments for laboratories, invested $725 million to double its therapeutic nucleic acids production capacity. This strategic move aims to meet the growing demand for high-quality active pharmaceutical ingredients used in drugs targeting various diseases, including cancer, cardiovascular issues, and rare and infectious diseases.

In January 2023, ALS Limited, an Australia-based testing labs operator, acquired Invitek Molecular GmbH for an undisclosed sum. With this acquisition, ALS Limited aims to expand its expertise and provide in-vitro diagnostics firms worldwide with custom development and contract manufacturing services in the nucleic acid labeling market. Invitek Molecular GmbH is a Germany-based manufacturer of molecular diagnostic tools operating in the nucleic acid labeling market.

Major companies operating in the nucleic acid labeling market include General Electric Company, F. Hoffman-La Roche AG, Thermo Fisher Scientific Inc., Merck Group, Roche Diagnostics Corporation, GE Healthcare Bio Sciences AB, Agilent Technologies Inc., PerkinElmer Inc., Bio-Rad Laboratories Inc., Cytiva, Qiagen N.V., Biotium Inc., Illumina Inc., LGC Group, Promega Corporation, New England Biolabs, Enzo Biochem Inc., LI-COR Biosciences Inc., Eurogentec S.A., OriGene Technologies Inc., BaseClear B.V., Vector Laboratories Inc., Bio-Synthesis Inc., BioCat GmbH, Jena Bioscience GmbH, LubioScience GmbH, GeneCopoeia Inc., Mirus Bio LLC, Daicel Arbor Biosciences.

North America was the largest region in the nucleic acid labeling market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the nucleic acid labeling market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa

The countries covered in the nucleic acid labeling market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA, Italy, Spain, Canada.

The nucleic acid labeling market consists of revenues earned by entities by providing services such as radiolabeling, biotinylation, fluorescence labeling, and enzyme labeling. The market value includes the value of related goods sold by the service provider or included within the service offering. The nucleic acid labeling market also includes sales of labeled nucleotides, labeling kits, labeling enzymes and detection reagents. Values in this market are 'factory gate' values, that is, the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors, and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD, unless otherwise specified).

The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

Nucleic Acid Labeling Global Market Report 2025 from The Business Research Company provides strategists, marketers and senior management with the critical information they need to assess the market.

This report focuses on nucleic acid labeling market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond.

Reasons to Purchase

Where is the largest and fastest growing market for nucleic acid labeling ? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward, including technological disruption, regulatory shifts, and changing consumer preferences? The nucleic acid labeling market global report from the Business Research Company answers all these questions and many more.

The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, competitive landscape, market shares, trends and strategies for this market. It traces the market's historic and forecast market growth by geography.

The forecasts are made after considering the major factors currently impacting the market. These include the technological advancements such as AI and automation, Russia-Ukraine war, trade tariffs (government-imposed import/export duties), elevated inflation and interest rates.

Scope

Table of Contents

1. Executive Summary

2. Nucleic Acid Labeling Market Characteristics

3. Nucleic Acid Labeling Market Trends And Strategies

4. Nucleic Acid Labeling Market - Macro Economic Scenario Including The Impact Of Interest Rates, Inflation, Geopolitics, Trade Wars and Tariffs, And Covid And Recovery On The Market

5. Global Nucleic Acid Labeling Growth Analysis And Strategic Analysis Framework

6. Nucleic Acid Labeling Market Segmentation

7. Nucleic Acid Labeling Market Regional And Country Analysis

8. Asia-Pacific Nucleic Acid Labeling Market

9. China Nucleic Acid Labeling Market

10. India Nucleic Acid Labeling Market

11. Japan Nucleic Acid Labeling Market

12. Australia Nucleic Acid Labeling Market

13. Indonesia Nucleic Acid Labeling Market

14. South Korea Nucleic Acid Labeling Market

15. Western Europe Nucleic Acid Labeling Market

16. UK Nucleic Acid Labeling Market

17. Germany Nucleic Acid Labeling Market

18. France Nucleic Acid Labeling Market

19. Italy Nucleic Acid Labeling Market

20. Spain Nucleic Acid Labeling Market

21. Eastern Europe Nucleic Acid Labeling Market

22. Russia Nucleic Acid Labeling Market

23. North America Nucleic Acid Labeling Market

24. USA Nucleic Acid Labeling Market

25. Canada Nucleic Acid Labeling Market

26. South America Nucleic Acid Labeling Market

27. Brazil Nucleic Acid Labeling Market

28. Middle East Nucleic Acid Labeling Market

29. Africa Nucleic Acid Labeling Market

30. Nucleic Acid Labeling Market Competitive Landscape And Company Profiles

31. Nucleic Acid Labeling Market Other Major And Innovative Companies

32. Global Nucleic Acid Labeling Market Competitive Benchmarking And Dashboard

33. Key Mergers And Acquisitions In The Nucleic Acid Labeling Market

34. Recent Developments In The Nucleic Acid Labeling Market

35. Nucleic Acid Labeling Market High Potential Countries, Segments and Strategies

36. Appendix

(주)글로벌인포메이션 02-2025-2992 kr-info@giikorea.co.kr
ⓒ Copyright Global Information, Inc. All rights reserved.
PC버전 보기